JACC Global cover art

All Episodes

JACC Global — 66 episodes

#
Title
1

AF Ablation and the Brain: Does It Improve Blood Flow and Cognition? | JACC Baran

2

Acute PE in Practice: An APAC View on the New AHA/ACC Guideline | JACC Baran

3

Marfan Syndrome: Timing Surgery Through Genetics | JACC Baran

4

Unraveling HCM Heterogeneity Using Circulating microRNAs | JACC Baran

5

Chagas Cardiomyopathy — Epidemiology Through Modern Clinical Trials | JACC Baran

6

Japanese Circulation Society 2026 Special — JACC at #26JCS | JACC Baran

7

Mild PVR in TAVR — A Small Leak, Long-Term Impact | JACC Baran

8

LDH in HFrEF — A Common Test, A Hidden Signal | JACC Baran

9

TAVR and HFrEF — Are We Fully Applying GDMT? | JACC Baran

10

TR and AFib After M-TEER: A Risk Interaction to Watch | JACC Baran

11

HFpEF: Normal by Echo, Abnormal by Hemodynamics | JACC Baran

12

Cardiac Sarcoidosis Beyond Suppression: Imaging and Biomarkers That Matter | JACC Baran

13

Coronary Revascularization in the Real World: Evidence, Policy, and Practice in Japan | JACC Baran

14

What Spontaneous Echo Contrast Reveals After Left Atrial Appendage Closure | JACC Baran

15

Too Old for Ablation? Insights from AF Patients Aged 80 and Above | JACC Baran

16

Japan’s Cardiovascular Playbook: A Living History Book of Prevention | JACC Baran

17

M-TEER: Challenging the Status Quo With Outcome-Driven Metrics | JACC Baran

18

PREVENT in East Asia: Can One Risk Score Fit All? | JACC Baran

19

“Just One Drink?” Think Again — Blood Pressure Says Bye to Alcohol | JACC Baran

20

CT-Based Plaque Norms: Rethinking Risk in Healthy Adults | JACC Baran

21

Leave Nothing Behind: The Current and Future of Drug-Coated Balloons in PCI | JACC Baran

22

A Global Look at Heart Disease: What the GBD Study Reveals | JACC Baran

23

Ten Seconds That Matter: Clinical Frailty Scale in Heart Failure | JACC Baran

24

When MRI Falls Short: ICE Identifies Arrhythmogenic Scars | JACC Baran

25

SimPub at AHA 2025 | JACC Baran

26

TAVR, von Willebrand Factor, and Bleeding: Refining High Bleeding Risk with CT-ADP | JACC Baran

27

Primetime for Cardiovascular AI: The PRIME 2.0 Checklist Explained | JACC Baran

28

Frailty Across the Spectrum of Ejection Fraction | JACC Baran

29

Patient Journeys of Angina: What ISCHEMIA Tells Us | JACC Baran

30

From Pixels to Precision: AI in Echocardiography | JACC Baran

31

Heart Failure in Japan’s Oldest-Old: A Super-Aging Challenge | JACC Baran

32

CHIPping the Code: Clonal Hematopoiesis and CV Outcomes | JACC Baran

33

Single Cells, Spatial Maps, Big Insights: Rewiring Heart Disease at the Molecular Level | JACC Baran

34

ARVC at 40+: Clinical Insights From a 20-Year Study

35

ESC Day 4 – JACC SimPub Spotlight | JACC Baran

36

ESC Day 3–JACC SimPub Spotlight | JACC Baran

37

ESC Day 2–JACC SimPub Spotlight | JACC Baran

38

ESC Day 1–JACC SimPub Spotlight | JACC Baran

39

Orthostatic Pulse Pressure and SGLT2 Inhibitors: Findings from PRESERVED-HF | JACC Baran

40

Eplerenone Insights on Aldosterone Dynamics: EPHESUS Revisited | JACC Baran

41

Primary Tricuspid Regurgitation and TEER: Insights from an International Cohort | JACC Baran

42

Targeting the Spin: RAP Ablation in Scar-Related VT | JACC Baran

43

ChinaCORE ACM Registry | ACC Asia (Chinese)

44

Sleep and Heart Failure: LV Function Findings from the ADVENT-HF Trial | JACC Baran

45

Chronic Stent Recoil: A Hidden Cost of Thinner Struts? | JACC Baran

46

Acoramidis and Early sTTR Rise: Biomarker-Driven Insights into Survival | JACC Baran

47

VT Prevention in Repaired Tetralogy of Fallot: Mapping SCAI and Minimizing ICDs | JACC Baran

48

Rethinking Rehab: ACTIVE-ADHF and the Power of Early Intervention | JACC Baran

49

Altshock-2 Through a Regional Lens: IABP in HF-CS | JACC Baran

50

Aortic Stenosis Under Pressure: Decoding Low-Gradient Risk Profiles | JACC Baran

51

Bridging Gaps for SCD Prevention in HCM: Why Regional Validation Matters | JACC Baran

52

Out-of-Hospital Cardiac Arrest in Septuagenarians, Octogenarians, and Nonagenarians in Japan: Trends and Patterns in Outcomes | JACC Baran

53

Zeroing In on Prevention: ARIC and the Future of Cardiovascular Risk | JACC Baran

54

From Hokkaido to ACC: NT-proBNP Screening for Pre-Heart Failure in Rural Japan | JACC Baran

55

Troponin in Translation: The 0/1-Hour Algorithm Across Asia | JACC Baran

56

Gold Cards & Hidden Triggers: A New Look at Afib | JACC Baran

57

Exploring High-Gradient Aortic Stenosis | JACC Baran

58

Federal Funding Cuts & Aortic Valve Replacement Outcomes | JACC Baran

59

Skype and Diaphragm Ultrasound in Heart Failure | JACC Baran

60

Bicuspid Advantage? Rethinking PPM After TAVR |JACC Baran

61

Diagnostic Performance and Clinical Impact of Photon-Counting Detector Computed Tomography in Coronary Artery Disease | JACC Baran

62

P2Y12 Inhibitor Pretreatment in Non–ST-Segment Elevation Acute Coronary Syndrome: The NCDR Chest Pain-MI Registry | JACC Baran

63

Introducing JACC-Baran & FINEARTS-HF Renal Function |JACC Baran

64

Breaking Barriers in CTEPH: The Global BPA Registry | JACC Baran

65

The Super Bowl & HCM Proteomics | JACC Baran

66

Monotherapy in HBR Patients: What STOPDAPT-3 Tells Us | JACC Baran